+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI Clinical Trial Imaging Market by Imaging Modality (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography), Clinical Application (Cardiology, Neurology, Oncology), End User, Trial Phase, Deployment Type, Technology Type - Global Forecast 2025-2030- Product Image
AI Clinical Trial Imaging Market by Imaging Modality (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography), Clinical Application (Cardiology, Neurology, Oncology), End User, Trial Phase, Deployment Type, Technology Type - Global Forecast 2025-2030- Product Image
New

AI Clinical Trial Imaging Market by Imaging Modality (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography), Clinical Application (Cardiology, Neurology, Oncology), End User, Trial Phase, Deployment Type, Technology Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120311
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Artificial intelligence driven imaging represents a paradigm shift in the design and execution of clinical trials enabling unprecedented precision in data acquisition and interpretation. The confluence of advanced algorithms with high-resolution imaging modalities is eroding traditional bottlenecks and unlocking new insights into disease progression safety signals and therapeutic efficacy. As stakeholders across the research ecosystem seek to harness these capabilities, it becomes imperative to understand the strategic implications of this technological transformation.

This executive summary distills critical developments within AI clinical trial imaging delivering an informed perspective on emerging trends regulatory considerations and sectoral dynamics. Anchored by rigorous research and expert validation it provides decision makers with a concise yet thorough foundation for strategic planning resource allocation and partnership development. By exploring shifts in the landscape segmentation insights regional variations and actionable recommendations, this document equips industry leaders with the intelligence required to navigate an increasingly complex environment.

Harnessing Disruptive Innovations in Data Analytics Machine Learning and Deep Neural Networks to Redefine Clinical Trial Imaging Workflows and Outcomes

The advent of machine learning and deep neural networks has catalyzed a fundamental redefinition of clinical trial imaging workflows. Innovations in cloud native architectures now allow for real time image processing and anomaly detection across geographically dispersed trial sites without compromising data integrity or compliance. Algorithmic improvements in convolutional neural networks have elevated lesion detection and volumetric quantification from niche research applications to core endpoints in pivotal trials.

Moreover, the integration of explainable AI tools is fostering greater transparency and regulatory confidence by mapping algorithmic decisions back to clinically meaningful features. This shift from manual review toward augmented interpretation has yielded faster adjudication cycles and more robust safety monitoring. As data pipelines mature, advanced analytics are enabling predictive modeling that anticipates patient recruitment challenges protocol deviations and endpoint success probabilities, thereby transforming trial design from reactive to proactive.

Assessing the Wide Repercussions of United States Trade Measures on Clinical Trial Imaging Equipment Software and Service Provision Dynamics

Recent trade measures implemented by the United States have introduced new considerations for developers and sponsors who rely on imported imaging hardware software and cloud based services. Adjustments in tariff schedules for diagnostic equipment have elevated capital expenditure requirements for trial sites, compelling sponsors to reassess procurement strategies and engage in more rigorous cost-benefit analyses. Software licensing structures and subscription models have likewise been influenced as vendors adapt pricing frameworks to offset increased import duties and supply chain constraints.

In parallel, service providers have responded by optimizing local partnerships and enhancing regional fulfillment networks to mitigate delivery delays. Strategic alliances with domestic manufacturers have emerged as an avenue to secure preferential pricing and reduce project timelines. These adaptive responses underscore the need for agile supply chain planning, contractual flexibility in vendor engagements and proactive scenario modeling to preserve trial momentum under evolving regulatory and economic conditions.

Unveiling Comprehensive Insights across Imaging Modalities Clinical Applications End Users Trial Phases Deployment Types and Technology Variants

A nuanced analysis of segmentation reveals how diverse imaging modalities, clinical applications and technological preferences are shaping the landscape of AI enabled trials. Computed tomography offerings now span both dual energy and low dose approaches, while magnetic resonance imaging capabilities differentiate along structural and functional parameters. Positron emission tomography, ultrasound and X-ray applications complement these core modalities to deliver multi-dimensional insights across therapeutic areas.

Clinical use cases extend from cardiology diagnostics and neurology assessments to oncology monitoring, where tumor detection and therapy evaluation benefit from specialized segmentation workflows tailored to brain, breast and lung neoplasms. Orthopedic studies leverage joint imaging analytics to quantify structural changes with precision. End user profiles encompass academic and research institutions, contract research organizations that offer full service and niche specialty solutions, hospitals and imaging centers differentiated into standalone diagnostic facilities and hospital affiliated departments, as well as pharmaceutical companies seeking integrated in-house imaging capabilities.

Trial phases progress sequentially from Phase Ia and Ib through Phase IIa and IIb, culminating in expansive Phase III and post-marketing Phase IV assessments, each demanding unique imaging protocols and data validation standards. Deployment environments vary between on-premise solutions hosted in data centers or in-house servers and cloud based platforms including hybrid cloud, private cloud and public cloud architectures. Underpinning all segments are core AI methodologies spanning deep learning paradigms like convolutional neural networks, generative adversarial networks and recurrent neural networks, alongside traditional machine learning models such as k nearest neighbors, random forest and support vector machines supplemented by rule based systems for automated anomaly detection.

Deciphering Regional Dynamics and Growth Trajectories in the Americas Europe Middle East Africa and Asia Pacific Imaging Sectors in Clinical Research

Regional dynamics illustrate distinct adoption curves and innovation ecosystems across the Americas, Europe Middle East Africa and Asia Pacific. In the Americas, a robust combination of established research infrastructures and progressive regulatory frameworks has accelerated the integration of AI imaging into large scale multi-site trials. Leading academic centers and specialized imaging hubs contribute to a collaborative environment where real world evidence and regulatory clarity support rapid proof of concept validations.

Across Europe Middle East and Africa, a mosaic of regulatory regimes underscores the importance of localized compliance strategies. Nations with unified regulatory bodies benefit from streamlined approvals, while high demand in oncology and neurology imaging has catalyzed investment in AI validation studies. Cross border partnerships leverage regional expertise to optimize trial design and data harmonization.

In the Asia Pacific region, expansive patient populations and rising healthcare investment are driving unprecedented demand for AI enabled imaging. Strategic initiatives in markets such as Japan, India and mainland China have prioritized domestic innovation in deep learning algorithms, creating fertile ground for partnerships between local technology firms and global imaging vendors. Together, these regional variations underscore the imperative for adaptive market entry approaches and dynamic resource allocation to maximize trial efficacy.

Profiling Leading Innovators and Strategic Alliances Shaping the Competitive Landscape of AI Powered Clinical Trial Imaging Solutions

A competitive review highlights a diverse ecosystem of incumbents and agile newcomers vying for leadership in AI powered clinical trial imaging. Established imaging hardware vendors have embarked on strategic acquisitions of software startups to embed AI capabilities directly into scanning platforms. Parallel to this, pure play software developers have forged alliances with contract research organizations to co-develop end to end imaging solutions that streamline data flow from acquisition to regulatory submission.

Further differentiation emerges through partnerships between cloud service providers and imaging specialists, enabling scalable infrastructure tailored to trial complexity. Companies focusing on deep learning frameworks have advanced lesion segmentation and volumetric analytics, while those specializing in reinforcement learning are exploring adaptive trial protocols that adjust imaging schedules based on interim findings. Collectively, these competitive maneuvers are accelerating the convergence of imaging, AI and cloud technologies within the clinical trial domain.

Implementing Strategic Roadmaps and Best Practices for Industry Leaders to Optimize AI Integration in Clinical Trial Imaging and Ensure Sustainable Growth

Industry leaders should prioritize the integration of advanced AI frameworks within existing imaging workflows to optimize trial timelines and data fidelity. By adopting hybrid deployment models, organizations can balance the security of on-premise platforms with the scalability of cloud native solutions. Collaborative alliances with domain experts in oncology and neurology imaging will enhance algorithm robustness and facilitate regulatory acceptance of AI validated endpoints.

In parallel, investing in explainable AI tools will strengthen stakeholder confidence and support transparent reporting practices. Organizations should establish cross functional teams combining data scientists, radiologists and clinical operations professionals to foster shared ownership of imaging and analysis processes. Scenario planning exercises addressing trade policy shifts can inform contingency strategies for equipment procurement and vendor selection. By embedding these recommendations into strategic roadmaps, decision makers can ensure resilient, compliant and efficient imaging operations that deliver actionable insights throughout the trial lifecycle.

Detailing Robust Research Methodologies Combining Primary Engagement Secondary Data Triangulation and Expert Validation for Clinical Trial Imaging Analysis

The research underpinning this summary combined qualitative and quantitative methods to deliver a comprehensive perspective on AI clinical trial imaging. Primary insights were gathered through in depth interviews with imaging directors clinical operations leads data scientists and regulatory experts from leading research institutions and contract research organizations. Secondary data sources encompassed peer reviewed publications clinical trial registries and regulatory guidelines from major authorities across key regions.

Data triangulation was achieved by cross referencing interview findings with real world trial outcomes and technical white papers, ensuring alignment between experiential insights and documented evidence. An expert validation panel provided critical review of emerging trends, methodology assumptions and thematic interpretations. While efforts were made to include diverse stakeholder viewpoints, the analysis acknowledges potential biases arising from the evolving regulatory landscape and the rapid pace of AI innovation.

Drawing Conclusive Strategic Perspectives on the Evolution Adoption and Future Directions of AI Powered Imaging in Clinical Trials for Informed Decision Making

Artificial intelligence driven imaging continues to redefine the boundaries of clinical trial science by enabling deeper insights into disease pathology, accelerating safety monitoring and improving endpoint precision. The convergence of advanced algorithms with high fidelity imaging modalities is creating a new era of adaptive trial design, where predictive analytics inform patient stratification and operational decision making.

As global regulatory bodies advance toward clearer guidelines for AI validation, stakeholders equipped with strategic intelligence and agile frameworks will be best positioned to capitalize on these innovations. By synthesizing market shifts, segmentation nuances and competitive dynamics, this summary empowers decision makers to chart a path toward more efficient, effective and evidence driven clinical trial imaging strategies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Imaging Modality
    • Computed Tomography
      • Dual Energy Computed Tomography
      • Low Dose Computed Tomography
    • Magnetic Resonance Imaging
      • Functional Magnetic Resonance Imaging
      • Structural Magnetic Resonance Imaging
    • Positron Emission Tomography
    • Ultrasound
    • X Ray
  • Clinical Application
    • Cardiology
    • Neurology
    • Oncology
      • Therapy Monitoring
      • Tumor Detection
      • Tumor Segmentation
        • Brain Tumors
        • Breast Tumors
        • Lung Tumors
    • Orthopedics
  • End User
    • Academic And Research Institutes
    • Contract Research Organizations
      • Full Service CROs
      • Specialty CROs
    • Hospitals And Imaging Centers
      • Diagnostic Centers
      • Hospital Affiliated Imaging Departments
    • Pharmaceutical Companies
  • Trial Phase
    • Phase I
      • Phase Ia
      • Phase Ib
    • Phase II
      • Phase IIa
      • Phase IIb
    • Phase III
    • Phase IV
  • Deployment Type
    • Cloud
      • Hybrid Cloud
      • Private Cloud
      • Public Cloud
    • On Premise
      • Data Centers
      • Inhouse Servers
  • Technology Type
    • Deep Learning
      • Convolutional Neural Networks
      • Generative Adversarial Networks
      • Recurrent Neural Networks
    • Machine Learning
      • K Nearest Neighbors
      • Random Forest
      • Support Vector Machines
    • Rule Based
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Merative LLC
  • Dassault Systèmes SE
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • ICON plc
  • Medpace Holdings, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of federated learning frameworks for multi-site medical image data privacy and collaborative AI model development
5.2. Adoption of deep learning-based lesion segmentation tools for accurate multicenter oncology trial outcome assessments
5.3. Real-time AI-driven quality control pipelines for standardized imaging data acquisition and annotation in global trials
5.4. Expansion of synthetic image generation techniques to augment limited datasets for rare disease clinical trial imaging
5.5. Implementation of explainable AI algorithms to enhance clinician trust and support regulatory approval of imaging biomarkers
5.6. Utilization of multimodal AI platforms combining radiomics and genomics for predictive treatment response in oncology studies
5.7. Development of automated image harmonization solutions to reduce scanner variability across international trial sites
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI Clinical Trial Imaging Market, by Imaging Modality
8.1. Introduction
8.2. Computed Tomography
8.2.1. Dual Energy Computed Tomography
8.2.2. Low Dose Computed Tomography
8.3. Magnetic Resonance Imaging
8.3.1. Functional Magnetic Resonance Imaging
8.3.2. Structural Magnetic Resonance Imaging
8.4. Positron Emission Tomography
8.5. Ultrasound
8.6. X Ray
9. AI Clinical Trial Imaging Market, by Clinical Application
9.1. Introduction
9.2. Cardiology
9.3. Neurology
9.4. Oncology
9.4.1. Therapy Monitoring
9.4.2. Tumor Detection
9.4.3. Tumor Segmentation
9.4.3.1. Brain Tumors
9.4.3.2. Breast Tumors
9.4.3.3. Lung Tumors
9.5. Orthopedics
10. AI Clinical Trial Imaging Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.3.1. Full Service CROs
10.3.2. Specialty CROs
10.4. Hospitals and Imaging Centers
10.4.1. Diagnostic Centers
10.4.2. Hospital Affiliated Imaging Departments
10.5. Pharmaceutical Companies
11. AI Clinical Trial Imaging Market, by Trial Phase
11.1. Introduction
11.2. Phase I
11.2.1. Phase Ia
11.2.2. Phase Ib
11.3. Phase II
11.3.1. Phase IIa
11.3.2. Phase IIb
11.4. Phase III
11.5. Phase IV
12. AI Clinical Trial Imaging Market, by Deployment Type
12.1. Introduction
12.2. Cloud
12.2.1. Hybrid Cloud
12.2.2. Private Cloud
12.2.3. Public Cloud
12.3. On Premise
12.3.1. Data Centers
12.3.2. Inhouse Servers
13. AI Clinical Trial Imaging Market, by Technology Type
13.1. Introduction
13.2. Deep Learning
13.2.1. Convolutional Neural Networks
13.2.2. Generative Adversarial Networks
13.2.3. Recurrent Neural Networks
13.3. Machine Learning
13.3.1. K Nearest Neighbors
13.3.2. Random Forest
13.3.3. Support Vector Machines
13.4. Rule Based
14. Americas AI Clinical Trial Imaging Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa AI Clinical Trial Imaging Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific AI Clinical Trial Imaging Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GE HealthCare Technologies, Inc.
17.3.2. Siemens Healthineers AG
17.3.3. Koninklijke Philips N.V.
17.3.4. Canon Medical Systems Corporation
17.3.5. Merative LLC
17.3.6. Dassault Systèmes SE
17.3.7. IQVIA Holdings Inc.
17.3.8. Laboratory Corporation of America Holdings
17.3.9. ICON plc
17.3.10. Medpace Holdings, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AI CLINICAL TRIAL IMAGING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AI CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AI CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. AI CLINICAL TRIAL IMAGING MARKET: RESEARCHAI
FIGURE 28. AI CLINICAL TRIAL IMAGING MARKET: RESEARCHSTATISTICS
FIGURE 29. AI CLINICAL TRIAL IMAGING MARKET: RESEARCHCONTACTS
FIGURE 30. AI CLINICAL TRIAL IMAGING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AI CLINICAL TRIAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DUAL ENERGY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DUAL ENERGY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY LOW DOSE COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY LOW DOSE COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY FUNCTIONAL MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY FUNCTIONAL MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY STRUCTURAL MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY STRUCTURAL MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY BREAST TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY BREAST TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY LUNG TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY LUNG TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY FULL SERVICE CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY FULL SERVICE CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY SPECIALTY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY SPECIALTY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITAL AFFILIATED IMAGING DEPARTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITAL AFFILIATED IMAGING DEPARTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IA, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IA, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IB, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IB, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IIB, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IIB, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DATA CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DATA CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY INHOUSE SERVERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY INHOUSE SERVERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY K NEAREST NEIGHBORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY K NEAREST NEIGHBORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY RANDOM FOREST, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY RANDOM FOREST, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY SUPPORT VECTOR MACHINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY SUPPORT VECTOR MACHINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY RULE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY RULE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES AI CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 223. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 224. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 225. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 226. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 227. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 228. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 229. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 234. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 235. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 238. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 239. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 240. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 241. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 242. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 243. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 244. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 245. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 246. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 247. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 248. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 249. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 250. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 251. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 252. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 253. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 254. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 255. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 256. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 257. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 258. CANADA AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 259. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 260. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 261. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 262. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 263. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 264. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 265. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 268. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 269. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 270. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 271. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 274. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 275. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 276. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY HOSPITALS AND IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 277. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 278. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 279. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 280. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 281. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 282. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 283. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2024 (USD MILLION)
TABLE 284. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEPLOYMENT TYPE, 2025-2030 (USD MILLION)
TABLE 285. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 286. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 287. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 289. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 292. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 293. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 294. MEXICO AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY TUMOR SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL AI CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGAN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI Clinical Trial Imaging market report include:
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Merative LLC
  • Dassault Systèmes SE
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • ICON plc
  • Medpace Holdings, Inc.

Related Topics

Related Reports

Imaging CRO Market by Provider Types, Service Type, Imaging Modality, Phase of Clinical Trials, Indication, End-User - Global Forecast 2025-2030 - Product Image

Imaging CRO Market by Provider Types, Service Type, Imaging Modality, Phase of Clinical Trials, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Clinical Trial Imaging Market by Product & Service (Services, Software), Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging), Therapeutic area, End-User - Global Forecast 2025-2030 - Product Image

Clinical Trial Imaging Market by Product & Service (Services, Software), Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging), Therapeutic area, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Modality (Computed Tomography Scan, Magnetic Resonance Imaging), By Therapeutic Area, By Services, By End Use, Region, And Segment Forecasts, 2025 - 2030 - Product Image

Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Modality (Computed Tomography Scan, Magnetic Resonance Imaging), By Therapeutic Area, By Services, By End Use, Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Clinical Trial Imaging Market Report and Forecast 2025-2034 - Product Image

Clinical Trial Imaging Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029 - Product Image

Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029

  • Report
  • 249 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.